US Patent Issued to Amgen, AMGEN RESEARCH (MUNICH) on March 25 for "Anti-CCR8 antibodies and uses thereof" (German, Canadian, American Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,411, issued on March 25, was assigned to Amgen Inc. (Thousand Oaks, Calif.) and AMGEN RESEARCH (MUNICH) GmbH (Munich).

"Anti-CCR8 antibodies and uses thereof" was invented by Nathan William Pierce (Mountain View, Calif.), Agnieszka Kielczewska (Vancouver, Canada), Wentao Chen (Thousand Oaks, Calif.), Olivier Nolan-Stevaux (Millbrae, Calif.), Darren L. Bates (Oak Park, Calif.), Lisa Winkel (Munich), Christoph Dahlhoff (Geretsried, Germany), Tobias Raum (Eurasburg, Germany), Claudia Bluemel (Munich) and Jonas Karl-Josef Honer (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides anti-CCR8 antibodies and antigen-binding...